Pfizer to appeal invalidated Celebrex patent
March 12, 2014 at 15:00 PM EDT
Pharmaceutical giant Pfizer Inc. said Wednesday afternoon it will appeal a ruling that invalidated a key patent extension related to Celebrex...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.